ATE56445T1 - Pharmacologisch aktive propionylanilide. - Google Patents

Pharmacologisch aktive propionylanilide.

Info

Publication number
ATE56445T1
ATE56445T1 AT86105409T AT86105409T ATE56445T1 AT E56445 T1 ATE56445 T1 AT E56445T1 AT 86105409 T AT86105409 T AT 86105409T AT 86105409 T AT86105409 T AT 86105409T AT E56445 T1 ATE56445 T1 AT E56445T1
Authority
AT
Austria
Prior art keywords
propionylanilides
pharmacologically active
morbid
cold
useful
Prior art date
Application number
AT86105409T
Other languages
English (en)
Inventor
Egidio Molinari
Original Assignee
Erregierre Ind Chim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erregierre Ind Chim filed Critical Erregierre Ind Chim
Application granted granted Critical
Publication of ATE56445T1 publication Critical patent/ATE56445T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT86105409T 1985-05-15 1986-04-18 Pharmacologisch aktive propionylanilide. ATE56445T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20726/85A IT1191617B (it) 1985-05-15 1985-05-15 Propionilanilidi farmacologicamente attive
EP86105409A EP0202482B1 (de) 1985-05-15 1986-04-18 Pharmacologisch aktive Propionylanilide

Publications (1)

Publication Number Publication Date
ATE56445T1 true ATE56445T1 (de) 1990-09-15

Family

ID=11171140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86105409T ATE56445T1 (de) 1985-05-15 1986-04-18 Pharmacologisch aktive propionylanilide.

Country Status (11)

Country Link
US (1) US4639449A (de)
EP (1) EP0202482B1 (de)
JP (1) JPS61263966A (de)
AT (1) ATE56445T1 (de)
CA (1) CA1260470A (de)
DE (1) DE3674060D1 (de)
DK (1) DK222886A (de)
ES (1) ES8706653A1 (de)
IT (1) IT1191617B (de)
NO (1) NO861917L (de)
PT (1) PT82535B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518375A1 (de) * 1965-06-08 1969-08-14 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-halogenbenzylaminen
US3769408A (en) * 1965-06-08 1973-10-30 Boehringer Sohn Ingelheim Pharmaceutical compositions containing a halo-substituted 2-amino-benzylamine-morpholide or a salt thereof

Also Published As

Publication number Publication date
DK222886D0 (da) 1986-05-14
IT1191617B (it) 1988-03-23
PT82535A (en) 1986-06-01
DK222886A (da) 1986-11-16
NO861917L (no) 1986-11-17
JPS61263966A (ja) 1986-11-21
DE3674060D1 (de) 1990-10-18
ES8706653A1 (es) 1987-07-01
US4639449A (en) 1987-01-27
PT82535B (en) 1987-09-23
EP0202482A1 (de) 1986-11-26
ES554933A0 (es) 1987-07-01
EP0202482B1 (de) 1990-09-12
CA1260470A (en) 1989-09-26
IT8520726A0 (it) 1985-05-15

Similar Documents

Publication Publication Date Title
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
SE9504661D0 (sv) New compounds
ES8500056A1 (es) Procedimiento para la preparacion de derivados de imidazol.
ATE86668T1 (de) Antidiabetikaverbindungen.
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ATE87662T1 (de) Antidiabetikaverbindungen.
ES466850A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-imi- dazolidinilidenbenzamina.
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE56445T1 (de) Pharmacologisch aktive propionylanilide.
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
SE9802538D0 (sv) New pharmaceutically active compounds
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
TR199701604T2 (xx) Pirol t�revleri i�in yeni ba�vuru
ES8106156A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
SE9603284D0 (sv) New compounds
SU1783774A1 (ru) Натриевая соль n-(3-хлорбутен-2-ил)антраниловой кислоты, проявляющая противовоспалительную и анальгетическую активность
SU1075674A1 (ru) 2,3,2,3-Тетрагидро-3,3-тетрацианметилен-5,5-бис-as-триазин, обладающий противовоспалительной и анальгетической активностью
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties